Todd Boudreaux, VP of Strategic Partnerships
2015-08-30
Todd was diagnosed with Type 1 diabetes in 2000, and has been unofficially advocating for T1D ever since. Before joining the team at Beyond Type 1, Todd wrote and produced television shows for Discovery Channel, Travel Channel and Animal Planet. When he’s not in the office, you can usually find him at a baseball game, traveling or drawing on his Etch A Sketch. You can also follow him on instagram @toddboo.
Written by Todd
The Benefits of Using a Smart Insulin Pen
Endocrinologist Anne Peters, MD. discusses the benefits of using a smart pen to help you manage insulin doses for type 1 or type 2 diabetes.MORE
Lilly Issues Voluntary Nationwide Recall of One Lot of Glucagon Emergency Kit
Lilly Diabetes announced the voluntary recall of lot D239382D, Expiration April 2022 of Glucagon Emergency Kits.MORE
January AI Looks to Revolutionize Personalized Diabetes Care
January AI is a precision health company designed to encourage small lifestyle changes and habit-building. Founder and CEO, Noosheen Hashemi, spoke with Beyond Type 2 about the company and its future.MORE
Talking COVID-19’s Impact on ADCES with President Kellie Antinori-Lent
ADCES President Kellie Antinori-Lent talks to Beyond Type 2 about moving the ADCES Annual Conference to a virtual platform due to the COVID-19 pandemic, how diabetes care and education specialists are...MORE
White House Issues Executive Orders Taking Aim at Drug Prices
On Friday, July 24 President Trump announced and signed four Executive Orders aimed at lowering prescription drug prices in the U.S.MORE
Nationwide Study in France Shows Dramatic Drop in DKA in Type 1 and Type 2 after Starting on FreeStyle Libre
The study included more that 70,000 patients living with diabetes and DKA rates were reduced by 52% for patients with T1D and 47% for patients with T2D.MORE
Closed Loop Updates: Omnipod Horizon and Medtronic 780G data presented at ADA 2020
Data from four new clinical trials involving Hybrid Closed Loop systems, Medtronic 780G and Omnipod 5 Powered by Horizon was presented at ADA 2020.MORE
New Program Offers $35 Monthly Copays for Lilly Insulins
Eli Lilly announced a new program that allows people in the US to fill their monthly prescription of Lilly insulin for $35 per month with a copay card.MORE
Insulin Access in a Pandemic: An Interview with Wade Neucks of Lilly Diabetes
Beyond Type 1 chatted with Wade Neucks of Lilly Diabetes about expectations of insulin access in the midst of the COVID-19 pandemic.MORE
COVID-19 Diabetes Supply Chain Updates
Here, you'll find continuous updates on the status of the diabetes supply chain, with up to date information from all major insulin and device manufacturers as it relates to COVID-19.MORE
Omnipod Closed Loop Technology to be Compatible with Both Abbott and Dexcom CGMs
Abbott and Dexcom announced formal partnerships with Insulet to be compatible as CGMs on the Omnipod Horizon Automated Insulin Delivery System. MORE
Dash, Tidepool Loop, Horizon: the Future of Omnipod
The Omnipod Dash is now widely available, and two hybrid closed loops, Omnipod Horizon and DASH + Tidepool are expected in the second half of 2020.MORE
One on One With Insulet CEO Shacey Petrovic
Insulet CEO Shacey Petrovic spoke with Beyond Type 1 about her personal connection to T1D, the importance of access, the future of Omnipod and more.MORE
One on One with ADA CEO Tracey Brown
Tracey D. Brown is the CEO of the American Diabetes Association. BT2 had a candid conversation with Brown about community needs + what's ahead for the ADA.MORE
The Future of Diabetes Care with AADE President Karen Kemmis
Karen Kemmis, the President of AADE recently spoke with Beyond Type 2 about the exciting changes happening at AADE and the future of diabetes care. MORE
Study Shows Combination Therapy Leads to Better Outcomes for Newly Diagnosed T2D Patients
The new study shows combination therapy in patients newly diagnosed with type 2 diabetes provides better outcomes than metformin alone.MORE
Half-Price Generics of NovoLog and NovoLog Mix Announced by Novo Nordisk
Novo Nordisk announced that authorized generic versions of NovoLog and NovoLog Mix will be made available on January 2, 2020.MORE
Research Shows Fridges Might Be Destroying Insulin
A 16-month study has shown that 79% of insulin is kept at temperatures outside of the recommended range. Insulin stored in the fridge is at a much higher risk. MORE
